See what’s changing first. Know which accounts matter next.
Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
MOYOM Biotech secures a financing round from Cathay Capital to accelerate global growth in regenerative aesthetics. This investment supports the company's next phase of development.
Round Type
Venture
ShanghaiManufacturingBiotechnologyHealth CareInvestors
Description
MOYOM Biotech, specializing in regenerative aesthetic biomaterials, has completed a new financing round from the Cathay Consumer Co-Creation Fund. This investment will support its growth and innovation in the beauty and medical aesthetics industry. Founded in 2018, MOYOM focuses on nanomedical biomaterials and implantable medical devices. The financing marks an important milestone in the company's development.
Fundz sees it the moment MOYOM Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MOYOM Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.